Cortexyme Inc (CRTX)

NASDAQ
13.04
-1.04(-7.39%)
After Hours
12.91
-0.13(-1.00%)
- Real-time Data
  • Volume:
    1,125,412
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    12.70 - 14.06

CRTX Overview

Prev. Close
14.08
Day's Range
12.7-14.06
Revenue
-
Open
13.98
52 wk Range
11.54-121.49
EPS
-2.94
Volume
1,125,412
Market Cap
389.6M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,883,171
P/E Ratio
-
Beta
-
1-Year Change
-66.17%
Shares Outstanding
29,877,608
Next Earnings Date
Mar 15, 2022
What is your sentiment on Cortexyme Inc?
or
Market is currently closed. Voting is open during market hours.

Cortexyme Inc Company Profile

Employees
38

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer’s disease and other degenerative disorders. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer’s disease. Cortexyme, Inc. has a partnership with Parkinson Study Group. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellSellStrong Sell
SummaryStrong BuyBuyStrong SellStrong SellStrong Sell
  • something is going on. it will go up to 30 soon
    0
    • This is the price target from HC Hainwright (they corrected it from 200, LOL).
      0
  • We may get Alzheimer earlier than break-even.
    0
    • This algo trading confuses all technical analysis.
      0
      • time travel is possible, here you can see 2019 ipo prices.
        0
        • It will back to 30 in 15 days.
          0
          • 15 days pases and fell another 35%
            0
        • Doesnt go from 115 to 15 for nothing. This company is done
          1
          • Back to 15?
            0
            • 28
              0
          • good buy at this stage
            1
            • Is this stock dead? I just bought @16
              0
              • Actually, the study didn't fail completely. The drug showed positive effect among specific group. I expect the bounce to $27
                0
            • Why the massive drop?
              0
              • Theta gang ********
                0
                • So this seems to be a very good company. Why only worth $3B?
                  1
                  • why down?
                    0
                    • These guys are on to something. Hopefully this will crater before positive news comes out. This will run sooner or later
                      1
                      • Any idea what trigged the race?
                        0
                        • what a race man lol
                          0
                          • this isnt looking too good folks
                            0
                            • wow who would expect that, luckily bought at 25 sold at 32
                              0
                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.